首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of hematology & oncology

缩写:J HEMATOL ONCOL

ISSN:N/A

e-ISSN:1756-8722

IF/分区:47.8/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引2172条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Serena Pillozzi,Elisa Giommoni,Giulia Petroni et al. Serena Pillozzi et al.
Survival in metastatic pancreatic ductal adenocarcinoma (mPDAC) has long been limited by a dismal second-line therapeutic ceiling dictated by conventional chemotherapy. However, breakthrough data from the ASCO 2026 Annual Meeting and the pu...
Ming-Yu Lai,Hao-Xiang Wu,Ming-Ming He et al. Ming-Yu Lai et al.
While multiple phase III trials have established the survival benefit of adding a programmed cell death protein 1 (PD-1) antibody to first-line chemotherapy in patients with human epidermal growth factor receptor 2 (HER2)-negative advanced ...
Monika Szczepanowski,Johanna Richter,Sonja Bendig et al. Monika Szczepanowski et al.
Background: Baseline CD20 expression ≥ 20% in B-cell acute lymphoblastic leukemia (B-ALL) has been associated with poorer outcomes, which improved after rituximab introduction into frontline therapy for CD20-positive cas...
Guoqing Li,Wenlong Wang Guoqing Li
Copper, an essential trace element with dual functions in cancer progression, drives tumor growth via oncogenic signaling, metabolic plasticity, and extracellular matrix remodeling. By contrast, copper overload triggers cuproptosis, a form ...
Jingyu Tan,Tao Wen,Jian Liu et al. Jingyu Tan et al.
Cancer stem cells (CSCs) represent functionally defined and phenotypically plastic tumor cell populations implicated in therapeutic resistance, relapse, and metastasis. CSC plasticity is regulated through coordinated stemness signaling and ...
Ignacio Melero,María de Miguel,Elena Garralda Cabanas et al. Ignacio Melero et al.
Background: Resistance to anti-PD-1/PD-L1 therapy is a major unmet need. Growth Differentiation Factor 15 (GDF-15) has been identified as a key resistance factor for anti-PD-1/PD-L1 immunotherapy. Visugromab, a neutralizi...
Liyuan Qiao,Leyang Wu,Yihan Xiao et al. Liyuan Qiao et al.
The concept of bacterial therapy dates back over a century to clinical observations that incidental infections could induce tumor regression. Recent advances in genetic engineering and synthetic biology have since transformed bacteria into ...
Yuqian Li,Xinlin Liu,Fuyuan Zhang et al. Yuqian Li et al.
Antibody-oligonucleotide conjugates (AOCs) have emerged as a promising therapeutic platform that integrates the targeting capability of antibodies with the gene-regulatory potential of oligonucleotide payloads. By enabling cell or tissue se...
Yan-Ruide Li,Zhengyao Shao,Haochen Nan Yan-Ruide Li
Advances presented at the 2026 American Association for Cancer Research (AACR) Annual Meeting highlight a shift from standalone artificial intelligence (AI) models to integrated, agentic systems across oncology. Platforms such as Synapse en...
Yangzi Li,Xuan Wang,Shangkun Zhang et al. Yangzi Li et al.
Background: CAR-T therapy is effective in hematologic cancers but faces challenges in solid tumors due to antigen heterogeneity and an immunosuppressive tumor microenvironment (TME). Systemic CTLA-4 blockade enhances immu...